219 related articles for article (PubMed ID: 18583138)
1. Synthesis and biological evaluation of new disubstituted analogues of 6-methoxy-3-(3',4',5'-trimethoxybenzoyl)-1H-indole (BPR0L075), as potential antivascular agents.
Ty N; Dupeyre G; Chabot GG; Seguin J; Tillequin F; Scherman D; Michel S; Cachet X
Bioorg Med Chem; 2008 Aug; 16(15):7494-503. PubMed ID: 18583138
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of indole compounds derived from combretastatin A4: synthesis and biological screening of 5-phenylpyrrolo[3,4-a]carbazole-1,3-diones as potential antivascular agents.
Ty N; Dupeyre G; Chabot GG; Seguin J; Quentin L; Chiaroni A; Tillequin F; Scherman D; Michel S; Cachet X
Eur J Med Chem; 2010 Sep; 45(9):3726-39. PubMed ID: 20538383
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of (3,4,5-trimethoxyphenyl)indol-3-ylmethane derivatives as potential antivascular agents.
Dupeyre G; Chabot GG; Thoret S; Cachet X; Seguin J; Guénard D; Tillequin F; Scherman D; Koch M; Michel S
Bioorg Med Chem; 2006 Jul; 14(13):4410-26. PubMed ID: 16529936
[TBL] [Abstract][Full Text] [Related]
4. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
Liou JP; Chang YL; Kuo FM; Chang CW; Tseng HY; Wang CC; Yang YN; Chang JY; Lee SJ; Hsieh HP
J Med Chem; 2004 Aug; 47(17):4247-57. PubMed ID: 15293996
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents.
Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Tan UK; Yeh TK; Kuo CC; Chang YW; Lu PH; Tung YS; Lin KT; Chang JY; Hsieh HP
ChemMedChem; 2006 Oct; 1(10):1106-18. PubMed ID: 16952120
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo biological evaluation of new 4,5-disubstituted 1,2,3-triazoles as cis-constrained analogs of combretastatin A4.
Mur Blanch N; Chabot GG; Quentin L; Scherman D; Bourg S; Dauzonne D
Eur J Med Chem; 2012 Aug; 54():22-32. PubMed ID: 22647220
[TBL] [Abstract][Full Text] [Related]
7. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles.
Romagnoli R; Baraldi PG; Jung MK; Iaconinoto MA; Carrion MD; Remusat V; Preti D; Tabrizi MA; Francesca F; De Clercq E; Balzarini J; Hamel E
Bioorg Med Chem Lett; 2005 Sep; 15(18):4048-52. PubMed ID: 16005627
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
[TBL] [Abstract][Full Text] [Related]
10. Arylthioindoles, potent inhibitors of tubulin polymerization.
De Martino G; La Regina G; Coluccia A; Edler MC; Barbera MC; Brancale A; Wilcox E; Hamel E; Artico M; Silvestri R
J Med Chem; 2004 Dec; 47(25):6120-3. PubMed ID: 15566282
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors.
Romagnoli R; Baraldi PG; Sarkar T; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Hsieh HP; Hamel E
J Med Chem; 2008 Mar; 51(5):1464-8. PubMed ID: 18260616
[TBL] [Abstract][Full Text] [Related]
12. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of constrained heterocyclic analogues of combretastatin A4.
Arthuis M; Pontikis R; Chabot GG; Seguin J; Quentin L; Bourg S; Morin-Allory L; Florent JC
ChemMedChem; 2011 Sep; 6(9):1693-705. PubMed ID: 21732536
[TBL] [Abstract][Full Text] [Related]
14. Indole, a core nucleus for potent inhibitors of tubulin polymerization.
Brancale A; Silvestri R
Med Res Rev; 2007 Mar; 27(2):209-38. PubMed ID: 16788980
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of the first podophyllotoxin analogues as potential vascular-disrupting agents.
Labruère R; Gautier B; Testud M; Seguin J; Lenoir C; Desbène-Finck S; Helissey P; Garbay C; Chabot GG; Vidal M; Giorgi-Renault S
ChemMedChem; 2010 Dec; 5(12):2016-25. PubMed ID: 20979080
[TBL] [Abstract][Full Text] [Related]
16. Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure--activity relationship studies.
Putey A; Popowycz F; Do QT; Bernard P; Talapatra SK; Kozielski F; Galmarini CM; Joseph B
J Med Chem; 2009 Oct; 52(19):5916-25. PubMed ID: 19743863
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of 3-aroylindoles as anticancer agents: metabolite approach.
Wu YS; Coumar MS; Chang JY; Sun HY; Kuo FM; Kuo CC; Chen YJ; Chang CY; Hsiao CL; Liou JP; Chen CP; Yao HT; Chiang YK; Tan UK; Chen CT; Chu CY; Wu SY; Yeh TK; Lin CY; Hsieh HP
J Med Chem; 2009 Aug; 52(15):4941-5. PubMed ID: 19586033
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and antiviral activity of certain 3-substituted 2,5,6-trichloroindole nucleosides.
Williams JD; Chen JJ; Drach JC; Townsend LB
J Med Chem; 2004 Nov; 47(23):5753-65. PubMed ID: 15509174
[TBL] [Abstract][Full Text] [Related]
19. Domino approach to 2-aroyltrimethoxyindoles as novel heterocyclic combretastatin A4 analogues.
Arthuis M; Pontikis R; Chabot GG; Quentin L; Scherman D; Florent JC
Eur J Med Chem; 2011 Jan; 46(1):95-100. PubMed ID: 21112130
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents.
Gurjar MK; Wakharkar RD; Singh AT; Jaggi M; Borate HB; Shinde PD; Verma R; Rajendran P; Dutt S; Singh G; Sanna VK; Singh MK; Srivastava SK; Mahajan VA; Jadhav VH; Dutta K; Krishnan K; Chaudhary A; Agarwal SK; Mukherjee R; Burman AC
J Med Chem; 2007 Apr; 50(8):1744-53. PubMed ID: 17373779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]